Immunovia AB
IMMNOV
Rank in Stocks
#34534
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for... Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Share Price
$0.00739046
Market Cap
$4.97M
Change (1 day)
-3.69%
Change (1 year)
-78.59%
Country
SE
Trade Immunovia AB (IMMNOV)
Category
Healthcare
Stock price history for Immunovia AB (IMMNOV)
Highest end of day price: $0.01 on 2026-10-01
Lowest end of day price: $12.22 on 2018-01-01
Lowest end of day price: $12.22 on 2018-01-01
Stock price history of Immunovia AB from 2018 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -27.09% |
| 2025 | -57.69% |
| 2024 | -60.72% |
| 2023 | -94.55% |
| 2022 | -61.46% |
| 2021 | -45.87% |
| 2020 | -13.27% |
| 2019 | -8.33% |
| 2018 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $680.73 | 20.02% |
US
|
|
| $230.41 | 5.64% |
US
|
|
| $393.26 | 109.16% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $172.96 | 18.57% |
US
|
